Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studies
NefrologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Nephrologie & therapeutique
- Publicado em
- 21 jan 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studies
Jun-Yong Ou, Yuan-Wei Chen, Tian-Long Li, Hui-Zhi Shan, Sini Cui, Jun-Ju Lai, Yun Xiao
Descritores MeSH
- Glomerulonephritis, Membranous
- Autoantibodies
- Autoantigens
- Cyclophosphamide
- Female
- Humans
- Immunosuppressive Agents
- Male
- Recurrence
- Cyclosporine
Veja também
Estudos relacionados
- Evaluating rituximab against cyclophosphamide or cyclosporine in idiopathic membranous nephropathy: a meta-analysis
- Incidence and risk factors for recurrent membranous nephropathy after kidney transplantation: a systematic review and meta-analysis
- Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children
- Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis